Stem Cell Treatment Market Size & Share, by Stem Cell Type (Embryonic cells, Somatic cells, Pluripotent cells); Treatment Type (Allogeneic, Autologous, Syngeneic); Application (Regenerative Medicine, Drug Discovery, Development); Stem Cell Technology {Cell Acquisition, Cell Production, Cryopreservation} - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

Request Free Sample Copy

Report ID: 1329
Published Date: Apr 05, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Stem Cell Treatment Landscape

Stemedica Cell Technologies, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Pluristem Therapeutics Inc.
Thermo Fisher Scientific
Becton, Dickinson and Company
Advanced Cell Technology Inc.
Cellular Engineering Technologies Inc.
CellGenix GmbH
PromoCell GmbH
Kite Pharma
Genea Biocells

Browse Key Market Insights with Data Illustration:

Stem Cell Treatment Market Size & Share, Growth Forecasts 2035

In the News

A new drug application (IND) has been approved by FDA for Stemedica Cell Technologies, Inc. in order to treat moderate-to-severe COVID-19 with intravenous administration of allogeneic mesenchymal stem cells (MSCs). This new application has shown to be effective in treating the symptoms of moderate-to-severe COVID-19, such as inflammation, fever, and difficulty breathing.
An official announcement from Pluristem Therapeutics Inc. announced that the company's subsidiary, Pluristem Ltd., has signed a non-binding Memorandum of Understanding (MOU) with the Abu Dhabi Stem Cells Center (ADSCC), a special healthcare center for cell therapy and regenerative medicine based in the United Arab Emirates.

Frequently Asked Questions (FAQ)

The increasing prevalence of chronic and genetic diseases, along with the increasing awareness about the benefits of stem cell treatments are the major factors driving the market growth.

The market size of stem cell treatment is anticipated to attain a CAGR of ~14% over the forecast period, i.e., 2023-2035.

lack of availability of stem cell sources and the lack of standardization of stem cell treatments are estimated to be the growth hindering factors for the market expansion

The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Stemedica Cell Technologies, Inc., Pluristem Therapeutics Inc., Thermo Fisher Scientific, Becton, Dickinson and Company, Advanced Cell Technology Inc., Cellular Engineering Technologies Inc., CellGenix GmbH, PromoCell GmbH, Kite Pharma, Genea Biocells and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by stem cell type, treatment type, application, stem cell technology, and by region.

The allogeneic segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Companies Dominating the Stem Cell Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the stem cell treatment market?

What would be the CAGR of stem cell treatment market over the forecast period?

What are the challenges affecting the stem cell treatment market growth?

Which region will provide more business opportunities for growth of stem cell treatment market in future?

Who are the major players dominating the stem cell treatment market?

How are the company profiles selected?

What are the segments in the stem cell treatment market?

Which segment captures the largest market size in the treatment type segment in the stem cell treatment market?